Chronology of Committee Work

Committee Members Ask Ridge for Comprehensive Homeland Security Strategy

The minority members of the Committee on Government Reform ask Director of Homeland Security Ridge for a comprehensive national homeland security strategy so that they may gauge whether the Administration's reorganization proposal best serves the nation's security goals.

Letter from JPMorgan Chase on Enron Transactions

JPMorgan Chase responds to Rep. Waxman's June 3 request for more information on the company's transactions with Enron involving a special-purpose entity named Sequoia.

Rep. Waxman Releases Analysis of House Energy Bill

The conference between the U.S. House of Representatives and the U.S. Senate on energy legislation began today. Rep. Waxman released a detailed section-by-section analysis of H.R. 4, the House energy bill, which shows that H.R. 4 is not a coherent national energy policy but is instead a collection of special interest giveaways to large energy industry campaign contributors.

HHS Actions Contradict Expert Recommendations

Rep. Waxman and Rep. Elijah Cummings, ranking Democrat of the Criminal Justice Subcommittee, along with leaders of the Congressional Black Caucus, Congressional Hispanic Caucus, and Congressional Asian and Pacific American Caucus, write to HHS Secretary Tommy Thompson to protest HHS actions that contradict the Institute of Medicine's expert recommendations on how to eliminate racial and ethnic health disparities.

Evaluating California Energy Crisis Claims

Rep. Waxman re-evaluates claims about the causes of the energy crisis in light of the facts as they are now known a year after the California energy crisis.

Ridge Testifies Before the Committee

White House Office of Homeland Security Director Ridge testifies at a Committee hearing on "The Department of Homeland Security: An Overview of the President's Proposal."

Committee Hearings Provide Forum for Unsubstantiated Allegations About Vaccine Safety

In his opening statement at a hearing on vaccine safety, Rep. Waxman states that, with this series of hearings, Chairman Burton has repeatedly provided a forum for unsubstantiated allegations about vaccine safety that have alarmed and confused parents. Rep. Waxman also urges Chairman Burton drop his threats to subpoena patient information from the Vaccine Safety Datalink (VSD) project, a national database for monitoring vaccine safety, and instead accept the CDC's solution of working with the HMOs to create a process for allowing independent researchers access to the data.

Rep. Waxman Asks If Committee Will Investigate White House Officials Rove and Mehlman

In a letter to Chairman Burton, Rep. Waxman asks if the Committee will be investigating the apparent use of government time and resources by Karl Rove and Ken Mehlman, two senior White House officials, to develop a partisan analysis of Republican prospects in key House and Senate races.

Administration Considers Weakening Diesel Emissions Regulations

Rep. Waxman writes EPA Administrator Whitman to urge that the EPA not undermine diesel emissions requirements by allowing manufacturers to trade emission reduction credits between off-road and highway engines. Rep. Waxman also expresses concern that EPA would be collaborating with the Office of Management and Budget in developing this new proposal.

Permanent Estate Tax Repeal Would Enrich Wealthy and Worsen Deficit

The effort to make permanent the repeal of the estate tax would enrich a small group of wealthy Americans, while worsening the existing federal budget deficit. Among the beneficiaries of a permanent repeal are members of President Bush's cabinet, former officers of Enron, and key executives of other troubled companies. This small group of wealthy individuals would receive over $1 billion in potential tax savings.

Letter to JPMorgan Chase on Enron Transactions

Rep. Waxman again writes JPMorgan Chase to ask for more information on the company's transactions with Enron involving a special-purpose entity named Sequoia.

Bush Administration Contacts with Enron

Rep. Waxman released a report which identifies 112 contacts between Administration officials and Enron in 200, based on documents and other information disclosed by the Administration, press stories, and Enron’s 2001 lobbying disclosure reports.

Letter to Senator Lieberman on White House Enron Contacts

Rep. Waxman wrote Senator Joseph Lieberman, Chairman of the Governmental Affairs Committee investigating Enron, to detail the inaccuracies and omissions in the information that the White House has provided on Administration contacts with the company.

GAO Report on Challenges in Postal Irradiation

Rep. Waxman writes Postmaster General Potter and details a new GAO Report that examines the technological premises and logistical hurdles to mail irradiation in the U.S. Postal System.

Administration Asks Judge to Dismiss Lawsuit

The White House files a motion in court asking the judge to dismiss GAO's lawsuit.

Energy Report Draft Shows Task Force Considered California

Rep. Waxman has obtained a draft table of contents for the National Energy Plan dated Feb. 21, 2001 which makes specific reference to addressing the California energy crisis. Rep. Waxman asks Vice President Cheney to explain why the task force apparently considered and abandoned plans to address California's energy problems.

HHS Letter: CDC to Guide Lead Screening Policy

In response to an April 17 letter from Rep. Waxman and other members, HHS Secretary Thompson has promised to be guided by the experts at CDC in determining policies for testing children for lead poisoning, rejecting an ill-advised proposal to end universal screening under Medicaid for lead poisoning.

EPA E-mail: Energy Report Tried "Desperately" to Avoid California

Rep. Waxman asks Vice President Cheney, Energy Secretary Abraham, and EPA Administrator Whitman to explain an e-mail produced by EPA which indicates that the report released by the Vice President’s task force tried “desperately” to avoid mentioning California, the state with the most pressing energy crisis facing the country at the time.

Chairman Burton Asked to Drop Threats to Subpoena Patient Information from Vaccine Database

In a letter to Committee Chairman Dan Burton, Rep. Waxman asks that he drop his threats to subpoena patient information from the Vaccine Safety Datalink (VSD) project, a national database for monitoring vaccine safety. According to the CDC, a subpoena could lead to the collapse of the VSD database and jeopardize the medical privacy of millions of Americans.

Rep. Waxman Introduces Nursing Home Staffing Improvement Act of 2002

Rep. Waxman and other members introduced the Nursing Home Staffing Improvement Act (H.R. 4715) to establish minimum staffing levels for nursing homes. This bill implements staffing levels identified by the Department of Health and Human Services and would require that all nursing home residents receive at least four hours of nursing care each day.

Rep. Waxman Gives Statement on H.R. 4187, The Presidential Records Act

In a hearing on The Presidential Records Act, Rep. Waxman stated, "The Bush executive order, which changes the management of the Presidential Records Act, is seriously flawed. The order takes a law that was designed to make documents readily available to the public and establishes procedures that are designed to block access."

Questions for Administration Officials on Denial of Oxygenate Requirements Waiver

Rep. Waxman writes to Vice President Cheney, Energy Secretary Abraham, EPA Administrator Whitman, and OMB Director Daniels to inquire about the role of Enron and the MTBE industry in the denial of the California's request for a waiver from the federal oxygenate requirement. The denial of this waiver could result in higher gasoline prices and worse air quality for Californians.

Letter to Jeff Skilling on Responding to Questions

Reps. Waxman and John Dingell wrote to former Enron CEO Jeff Skilling asking him to respond to questions originally posed to him by Rep. Waxman on March 1.

Judge Enters Scheduling Order

The U.S. District Court judge hearing the GAO suit sets the schedule for briefs and oral argument.

FDA Reverses Decision on Pediatric Rule

The FDA announced a reversal of its decision to suspend the pediatric rule, but stated that the rule "needs to be updated."

Displaying Items 1251 to 1275 of 1458:

Previous Page • Next Page

[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9] • [10] • [11] • [12] • [13] • [14] • [15] • [16] • [17] • [18] • [19] • [20] • [21] • [22] • [23] • [24] • [25] • [26] • [27] • [28] • [29] • [30] • [31] • [32] • [33] • [34] • [35] • [36] • [37] • [38] • [39] • [40] • [41] • [42] • [43] • [44] • [45] • [46] • [47] • [48] • [49] • [50] • [51] • [52] • [53] • [54] • [55] • [56] • [57] • [58] • [59]